• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Biomarkers – A Market Briefing

$995.00 – $3,990.00

Clear
SKU: KLI1059917 Category: Biotechnology Market Research Pages: 90
  • Description
  • Table of Contents
  • Latest reports

Description

Personalized medicine, the use of therapies that are targeted to the individual patient, is a reality today, thanks to a growing emphasis on biomarker research. Biomarkers promise a smoother integration of diagnostics and therapeutics, and most importantly a reduction in time and cost for Phase I and II clinical trials.

Anyone looking to take advantage of the opportunities the market for biomarker research offers will find Kalorama’s Biomarkers: A Market Briefing an essential study of this emerging market. Not only does the report explain the types of biomarkers and their myriad diagnostic applications, it tracks current revenue and forecasts revenue for the following diagnostic segments:

  • Cancer (Breast, Ovarian, Prostate, Bladder and Cervical)
  • EGFR Testing
  • Stroke Diagnosis

Recently, interest in biomarkers has soared due to their proven ability to speed up pharmaceutical R&D efforts. Biomarkers can increase the efficiency and reduce the risks of the drug development process. New trial designs and clear guidelines for using efficacy and safety biomarkers in product development will increase the pace and reduce the cost of developing safe and effective medical products.

Biomarkers have been shown to reduce time and cost for Phase I and II clinical trials by replacing clinical endpoints. This is expected to produce the most profitable segment of the market for companies in this industry. Kalorama’s Biomarkers: A Market Briefing provides detailed information on how this promising application for biomarkers is already shaping the market, producing over $200 million in revenue and expected to quintuple in the next four years. The report details the revenues associated with clinical trials biomarker application through 2009, including data on geographic regional revenues.

Biomarkers: A Market Briefing discusses the major products currently marketed in each disease category as well as the important issues and trends that serious entrants into this market must take notice of. In-depth profiles of need-to-know companies in this market are provided, including:

  • Biophysical Corp.
  • Charles River Laboratories Inc.
  • Cyclacel Pharmaceuticals Inc.
  • DeCODE Genetics
  • Diologic Corp.
  • Health Discovery Corp.
  • Illumina Inc.
  • Imgenex Corp.
  • Insilicos LLC
  • Metabolon Inc.
  • Millennium Pharmaceuticals Inc.
  • Peakadilly
  • PPD Inc.
  • Proteome Sciences plc
  • Rules-Based Medicine Inc.
  • Targeted Molecular Diagnostics LLC

Kalorama’s trusted information-gathering process provides the most accurate study of the market for biomarkers available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies and in the biomarker arena. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Product managers, marketing managers, business development executives, advertising agency or investment firm executives, and information and research center librarians are among the individuals who will find this briefing on the emerging market for biomarkers essential.

Table of Contents

Chapter One: Executive Summary

  • The Importance of Biomarkers
    • Speed Drug Development
    • Predictive Diagnostics
  • Key Applications
    • Selected Clinical Trial Applications
    • Key Diagnostics
  • World Market Summary
    • Clinical Diagnostics
    • Clinical Trials
  • Methodology

Chapter Two: Introduction

  • In Perspective
    • What Are Biomarkers?
    • Surrogate Endpoints
  • Types of Biomarkers
  • Applications
    • Diagnostics
    • Drug Development
    • Imaging Biomarkers
  • Issues and Concerns

Chapter Three: Markets

  • Overview
  • Key Diagnostics Segments
    • Cancer
    • EGFR Testing
    • Stroke
  • Drug Development
    • Clinical Trials

Chapter Four: Company Profiles

  • Biophysical Corp.
  • Charles River Laboratories Inc.
  • Cyclacel Pharmaceuticals Inc.
  • deCODE Genetics
  • Enodar Biologic Corp.
  • Health Discovery Corp.
  • Illumina Inc.
  • Imgenex Corp.
  • Insilicos LLC
  • Metabolon Inc.
  • Millennium Pharmaceuticals Inc.
  • Peakadilly
  • PPD Inc.
  • Proteome Sciences plc
  • Rules-Based Medicine Inc.
  • Targeted Molecular Diagnostics LLC

List of Exhibits

  • Exhibit 1-1: World Market for Biomarkers in HER2 Breast Cancer Diagnostics 2006-2010
  • Exhibit 1-2: World Market for Biomarkers in Ovarian Cancer Diagnostics 2006-2010
  • Exhibit 1-3: World Market for Biomarkers in Cervical Cancer Diagnostics 2006-2010 Revenues (in millions)
  • Exhibit 1-4: Summary: World Market for Biomarkers in Clinical Trials 2006-2010
  • Exhibit 3-1: U.S. Market for HER2-Based Biomarkers for Breast Cancer 2006-2010
  • Exhibit 3-2: World Market for HER2-Based Biomarkers for Breast Cancer 2006-2010 Revenues (in millions)
  • Exhibit 3-3: US Market for Biomarkers for Ovarian Cancer 2006-2010
  • Exhibit 3-4: Market for Biomarkers for Ovarian Cancer 2006-2010
  • Exhibit 3-5: Market for Biomarkers for Cervical Cancer 2006-2010
  • Exhibit 3-6: World Market for Biomarkers for Cervical Cancer 2006-2010
  • Exhibit 3-7: US Market for Biomarkers for Prostate Cancer 2006-2010
  • Exhibit 3-8: World Market for Biomarkers for Prostate Cancer 2006-2010
  • Exhibit 3-9: US Market for Biomarkers for Bladder Cancer 2006-2010
  • Exhibit 3-10: World Market for Biomarkers for Bladder Cancer 2006-2010
  • Exhibit 3-11: US Market for Biomarkers for EGFR Testing 2006-2010
  • Exhibit 3-12: World Market for Biomarkers for EGFR Testing 2006-2010
  • Exhibit 3-13: US Market for Biomarkers for Stroke Diagnosis 2006-2010
  • Exhibit 3-14: World Market for Biomarkers for Stroke Diagnosis 2006-2010
  • Exhibit 3-15: U.S. Clinical Trial Market for Biomarkers by Phase (Number of Trials, Patients, Biomarker Patients, Cost per Test, Market Size) 2006
  • Exhibit 3-16 : World Clinical Trial Market for Biomarkers by Geographical Region (U.S., European Union, Asia) 2006
  • Exhibit 3-17: U.S. Clinical Trial Market for Biomarkers by Phase (Number of Trials, Patients, Biomarker Patients, Cost per Test, Market Size) 2007
  • Exhibit 3-18 : World Clinical Trial Market for Biomarkers by Geographical Region (U.S., European Union, Asia) 2007
  • Exhibit 3-19: U.S. Clinical Trial Market for Biomarkers by Phase (Number of Trials, Patients, Biomarker Patients, Cost per Test, Market Size) 2008
  • Exhibit 3-20 : World Clinical Trial Market for Biomarkers by Geographical Region (U.S., European Union, Asia) 2008
  • Exhibit 3-21: U.S. Clinical Trial Market for Biomarkers by Phase (Number of Trials, Patients, Biomarker Patients, Cost per Test, Market Size) 2009
  • Exhibit 3-22 : World Clinical Trial Market for Biomarkers by Geographical Region (U.S., European Union, Asia) 2009
  • Exhibit 3-23: U.S. Clinical Trial Market for Biomarkers by Phase (Number of Trials, Patients, Biomarker Patients, Cost per Test, Market Size) 2010
  • Exhibit 3-24 : World Clinical Trial Market for Biomarkers by Geographical Region (U.S., European Union, Asia) 2010

 

    The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024
    September 11, 2024
    Worldwide Sequencer Market, 2023-2028
    August 8, 2024
    The Worldwide Market for Liquid Biopsy, 6th Edition
    December 29, 2023
    The Market for RNA Sequencing, 3rd Edition
    September 8, 2023

Related products

  • Placeholder image

    Biomarkers – A Market Briefing

    $995.00 – $3,990.00
  • Placeholder image

    Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments – World Market

    $995.00 – $3,990.00
  • Placeholder image

    SNP Genotyping and Analysis Markets

    $1,995.00 – $7,990.00
  • Placeholder image

    Monoclonal Antibodies in Cancer Therapy: Emerging Products and Markets

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Clinical Diagnostics in India – Market Sector Analyses and Participant...Worldwide Market for Dialysis Equipment, Supplies, and Services, 2nd Edition,...
Scroll to top